幼年和成人起病多关节炎新型治疗反应模式及决定因素
本文综述了生物制剂和靶向合成改善病情抗风湿药(b/tsDMARDs)在多关节型幼年特发性关节炎(pJIA)与类风湿关节炎(RA)中疗效个体差异的病理生理、患者特异性、药物特异性及环境因素,指出虽有生物标志物可分层预测应答与否,但临床实用性有限,故提出以患者为中心、基于临床的个体化而非生物标志物驱动的精准医学策略。
要点
- pJIA与RA在疾病病理生理及b/tsDMARDs应答模式上具有相似性。
- b/tsDMARDs疗效在RA和pJIA个体患者间存在差异,应答决定因素多样复杂。
- 已发现的生物标志物多可分层预测应答与否,但临床实用者少。
核心结论
- 作者提出在JIA中采用务实、以患者为中心、基于临床的个体化方法,而非基于生物标志物的精准医学。
研究设计与样本
- 综述,讨论pJIA与RA中b/tsDMARDs个体治疗应答的病理生理、患者特异性、药物特异性及环境因素。
主要发现
- b/tsDMARDs彻底改变了多种风湿炎症性疾病的管理。
- pJIA与RA在疾病病理生理和b/tsDMARDs应答模式上显示相似性。
- 新型靶向药物疗效在RA和pJIA个体患者间存在差异。
- 应答异质性的机制和决定因素多样且复杂,使真正「精准」医学策略的开发极具挑战性。
- 已识别一些生物标志物可对应答或无应答可能性进行分层,但迄今很少在临床实践中证明有用,可能因治疗应答机制复杂。
临床怎么用
- 作者提出务实、以患者为中心且基于临床的方法,即在JIA中采用个体化而非基于生物标志物的精准医学。
局限性
- 迄今很少生物标志物在临床实践中证明有用,可能因治疗应答机制复杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Biologic and targeted synthetic DMARDs (b/tsDMARDs) have revolutionized the management of multiple rheumatic inflammatory conditions. Among these, polyarticular JIA (pJIA) and RA display similarities in terms of disease pathophysiology and response pattern to b/tsDMARDs. Indeed, the therapeutic efficacy of novel targeted drugs is variable among individual patients, in both RA and pJIA. The mechanisms and determinants of this heterogeneous response are diverse and complex, such that the development of true 'precision'-medicine strategies has proven highly challenging. In this review, we will discuss pathophysiological, patient-specific, drug-specific and environmental factors contributing to individual therapeutic response in pJIA in comparison with what is known in RA. Although some biomarkers have been identified that stratify with respect to the likelihood of either therapeutic response or non-response, few have proved useful in clinical practice so far, likely due to the complexity of treatment-response mechanisms. Consequently, we propose a pragmatic, patient-centred and clinically based approach, i.e. personalized instead of biomarker-based precision medicine in JIA.
引用
- Triaille C, Quartier P, De Somer L, et al. Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis. Rheumatology (Oxford). 2024. PMID: 37725352. doi:10.1093/rheumatology/kead490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。